|
DDX60 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.86630000000143E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.9595999999632E-06 |
| Normal-vs-Stage2 |
4.784100E-02 |
| Normal-vs-Stage3 |
8.467600E-02 |
| Normal-vs-Stage4 |
5.929600E-02 |
| Stage1-vs-Stage2 |
8.859000E-01 |
| Stage1-vs-Stage3 |
2.323500E-02 |
| Stage1-vs-Stage4 |
1.094600E-01 |
| Stage2-vs-Stage3 |
2.975000E-01 |
| Stage2-vs-Stage4 |
4.271400E-01 |
| Stage3-vs-Stage4 |
7.295800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.23789999999058E-05 |
| Normal-vs-AfricanAmerican |
4.826400E-01 |
| Normal-vs-Asian |
2.472600E-01 |
| Caucasian-vs-AfricanAmerican |
6.595600E-02 |
| Caucasian-vs-Asian |
8.080200E-01 |
| AfricanAmerican-vs-Asian |
3.028200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.583000E-04 |
| Normal-vs-Female |
1.378290E-04 |
| Male-vs-Female |
2.493400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.873400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.418310E-04 |
| Normal-vs-Age(61-80Yrs) |
6.649800E-04 |
| Normal-vs-Age(81-100Yrs) |
1.343380E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.541000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.227000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.145400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.993400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.567800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.627800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.444700E-04 |
| Normal-vs-Grade 2 |
5.99739999995741E-07 |
| Normal-vs-Grade 3 |
1.135510E-02 |
| Normal-vs-Grade 4 |
5.586600E-01 |
| Grade 1-vs-Grade 2 |
5.885200E-01 |
| Grade 1-vs-Grade 3 |
1.122970E-01 |
| Grade 1-vs-Grade 4 |
3.288100E-02 |
| Grade 2-vs-Grade 3 |
4.579100E-03 |
| Grade 2-vs-Grade 4 |
7.198900E-04 |
| Grade 3-vs-Grade 4 |
1.697590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.11050002316438E-09 |
| Normal-vs-ccB subtype |
2.305600E-01 |
| ccA subtype-vs-ccB subtype |
2.18240000005032E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.410830E-04 |
| Normal-vs-N1 |
4.814000E-01 |
| N0-vs-N1 |
4.812800E-01 |
|
|
